BRIEF-Jazz Pharmaceuticals comments on FDA nod for generic version of Xyrem

* Jazz Pharmaceuticals says it will evaluate FDA's waiver of

requirement for a single, shared system rems in connection with

approval of a generic version of Xyrem

Read more